• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌中 PD-1 和 PD-L1 的表达频率及其与淋巴结转移的关系:一项横断面研究。

Frequency of Expression of PD-1 and PD-L1 In Head And Neck Squamous Cell Carcinoma And their Association With Nodal Metastasis: A Cross-Sectional Study.

机构信息

Department of Histopathology, Armed Forces Institute of Pathology, National University of Medical Sciences, Rawalpindi, Pakistan.

Department of Oral Pathology, Army Medical College, Rawalpindi, Pakistan.

出版信息

Asian Pac J Cancer Prev. 2022 Feb 1;23(2):467-473. doi: 10.31557/APJCP.2022.23.2.467.

DOI:10.31557/APJCP.2022.23.2.467
PMID:35225458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9272636/
Abstract

OBJECTIVE

The objective of this study was to determine the Immunohistochemical expression of PD- 1, PD-L1 and its association with nodal metastasis in head and neck squamous cell carcinoma.

MATERIALS AND METHODS

A total of 66 cases were studied at Oral pathology/Histopathology, Armed forces Institute of Pathology (AFIP), Rawalpindi. The tissue sampling and processing yielded the formalin fixed, paraffin wax blocks. These blocks were cut into the thin sections (5 microns) by the microtome and then were mounted on the glass slides. This was followed by the routine H&E staining and then IHC staining (PD-1 and PD-L1) of these tissues mounted slides. For each case a definitive histological diagnosis was made. The two types of variables were analyzed. For qualitative variables frequencies and percentages were calculated whereas for quantitative variables means and standard deviations were analyzed. The Chi-square test then was applied to evaluate the significant difference and p-value of ≤0.05 was taken significant.

RESULTS

This study was conducted at Histology department, Armed Forces Institute of Pathology, Rawalpindi over a period of one year from June 2019 to June 2020. It revealed male and female patients with 66.7% (44 Cases) and 33.3% (22cases) percentages respectively. The mean age was found to be 59.53 ± 13.637 (mean ± SD) and the mandible (37.9%) was the most commonly affected site. In total of 66 cases, 48 (72.7%) cases with metastasis of lymph nodes were presented. Out of 66 cases ,47 (71.2%) cases showed positive expression of PD-1 in the TILs seen among the primary tumor of the specimens, whereas, 40 (60.6%) cases showed positive PD-L1 expression in tumor cells of primary tumor.In comparison, as out of 66 cases ,48 (72.5%) cases showed lymph nodes metastasis, out of which 45 showed positive expression for PD-1 and 25 out of those 48 cases showed positive expression for PD-L1 in metastatic lymph nodes.The p-value turned to be significant for PD-1 IHC expression and PD-L1 IHC expression in the primary tumorand metastatic lymph nodes.

CONCLUSION

A significant correlation was inferred among IHC expression of PD-1 and PD-L1 with lymph nodes metastasis. Accurate evaluation, analysis and precise management with aid of IHC markers results in initial and timely diagnosis and favorable treatment outcomes helping in the evaluation of disease course at preliminary diagnosis on incisional biopsies.

摘要

目的

本研究旨在确定 PD-1、PD-L1 的免疫组织化学表达及其与头颈部鳞状细胞癌淋巴结转移的关系。

材料和方法

在武装部队病理学研究所(AFIP)口腔病理学/组织病理学共研究了 66 例病例。组织取样和处理产生了福尔马林固定、石蜡包埋块。这些块通过切片机切成 5 微米的薄片,然后安装在载玻片上。然后对这些组织载玻片进行常规的 H&E 染色和免疫组织化学染色(PD-1 和 PD-L1)。对每个病例都做出明确的组织学诊断。分析了两种类型的变量。对于定性变量,计算了频率和百分比,而对于定量变量,分析了均值和标准差。然后应用卡方检验评估显著性差异,p 值≤0.05 被认为具有显著性。

结果

本研究在 2019 年 6 月至 2020 年 6 月期间在拉瓦尔品第武装部队病理学研究所的组织学系进行。结果显示,男性和女性患者分别占 66.7%(44 例)和 33.3%(22 例)。平均年龄为 59.53±13.637(均值±标准差),下颌骨(37.9%)是最常受累的部位。在 66 例患者中,有 48 例(72.7%)患者出现淋巴结转移。在 66 例患者中,有 47 例(71.2%)患者在标本原发肿瘤的肿瘤浸润淋巴细胞中显示 PD-1 阳性表达,而 40 例(60.6%)患者在原发肿瘤的肿瘤细胞中显示 PD-L1 阳性表达。相比之下,在 66 例患者中,有 48 例(72.5%)患者出现淋巴结转移,其中 45 例在转移性淋巴结中显示 PD-1 阳性表达,而在这 48 例中,有 25 例显示 PD-L1 阳性表达。PD-1 免疫组织化学表达和转移性淋巴结中的 PD-L1 免疫组织化学表达的 p 值具有显著性。

结论

PD-1 和 PD-L1 的免疫组织化学表达与淋巴结转移之间存在显著相关性。借助免疫组织化学标志物进行准确评估、分析和精确管理,可在初步诊断时进行初始和及时诊断,并获得有利的治疗结果,有助于在切取活检时评估疾病过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b3/9272636/d422f5b0976c/APJCP-23-467-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b3/9272636/3363f31203f3/APJCP-23-467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b3/9272636/851fd5a74a78/APJCP-23-467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b3/9272636/d422f5b0976c/APJCP-23-467-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b3/9272636/3363f31203f3/APJCP-23-467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b3/9272636/851fd5a74a78/APJCP-23-467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b3/9272636/d422f5b0976c/APJCP-23-467-g003.jpg

相似文献

1
Frequency of Expression of PD-1 and PD-L1 In Head And Neck Squamous Cell Carcinoma And their Association With Nodal Metastasis: A Cross-Sectional Study.头颈部鳞状细胞癌中 PD-1 和 PD-L1 的表达频率及其与淋巴结转移的关系:一项横断面研究。
Asian Pac J Cancer Prev. 2022 Feb 1;23(2):467-473. doi: 10.31557/APJCP.2022.23.2.467.
2
Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.口腔鳞状细胞癌与口腔癌前病变中 PD-L1 表达的比较。
Asian Pac J Cancer Prev. 2022 Dec 1;23(12):4039-4045. doi: 10.31557/APJCP.2022.23.12.4039.
3
PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.PD-1 和 PD-L1 在头颈部鳞癌原发灶及相关淋巴结转移中的表达及其对临床结局的影响。
Histopathology. 2018 Oct;73(4):573-584. doi: 10.1111/his.13646. Epub 2018 Jul 4.
4
[Comparison of programmed death-ligand 1 protein expression between primary tumors and lymph node metastatic lesions in oral squamous cell carcinoma].[口腔鳞状细胞癌中原发肿瘤与淋巴结转移灶程序性死亡配体1蛋白表达的比较]
Zhonghua Kou Qiang Yi Xue Za Zhi. 2022 Nov 9;57(11):1113-1118. doi: 10.3760/cma.j.cn112144-20220730-00424.
5
Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma.在口咽鳞状细胞癌中,PD-L1 和 TIL 评估中材料和方法选择的重要性。
Histopathology. 2018 Sep;73(3):500-509. doi: 10.1111/his.13650. Epub 2018 Jul 4.
6
CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity.CD274/PD-L1基因扩增和PD-L1蛋白表达是口腔鳞状细胞癌中的常见现象。
Oncotarget. 2016 Mar 15;7(11):12024-34. doi: 10.18632/oncotarget.7593.
7
Assessment of PD-L1 mRNA and protein expression in non-small cell lung cancer, head and neck squamous cell carcinoma and urothelial carcinoma tissue specimens using RNAScope and immunohistochemistry.使用 RNAScope 和免疫组织化学评估非小细胞肺癌、头颈部鳞状细胞癌和尿路上皮癌组织标本中的 PD-L1 mRNA 和蛋白表达。
PLoS One. 2019 Apr 15;14(4):e0215393. doi: 10.1371/journal.pone.0215393. eCollection 2019.
8
Negative prognostic behaviour of PD-L1 expression in tongue and larynx squamous cell carcinoma and its significant predictive power in combination with PD-1 expression on TILs.PD-L1表达在舌和喉鳞状细胞癌中的不良预后行为及其与肿瘤浸润淋巴细胞上PD-1表达联合时的显著预测能力。
BMC Immunol. 2024 Jan 16;25(1):7. doi: 10.1186/s12865-024-00597-0.
9
Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in F-FDG PET in Squamous Cell Carcinoma of the Head and Neck.头颈部鳞状细胞癌中肿瘤 PD-1 配体、免疫组化研究和 F-FDG PET 纹理特征的相关性。
Sci Rep. 2018 Jan 8;8(1):105. doi: 10.1038/s41598-017-18489-2.
10
Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.一种经验证可用于分析非小细胞肺癌和头颈部鳞状细胞癌的程序性细胞死亡配体-1免疫组织化学检测方法的开发。
Diagn Pathol. 2016 Oct 8;11(1):95. doi: 10.1186/s13000-016-0545-8.

引用本文的文献

1
Optimal lymph node yield for long-term survival in elderly patients with right-sided colon cancer: a large population-based cohort study.老年右侧结肠癌患者长期生存的最佳淋巴结获取量:一项基于大人群的队列研究。
BMC Cancer. 2025 Apr 1;25(1):590. doi: 10.1186/s12885-025-13987-3.

本文引用的文献

1
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma.头颈部鳞状细胞癌的肿瘤微环境与免疫逃逸。
Int J Oral Sci. 2021 Aug 2;13(1):24. doi: 10.1038/s41368-021-00131-7.
2
Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis.识别头颈部皮肤鳞状细胞癌预后的风险因素:系统评价和荟萃分析。
PLoS One. 2020 Sep 29;15(9):e0239586. doi: 10.1371/journal.pone.0239586. eCollection 2020.
3
How fragile we are.我们是多么脆弱。
Head Neck. 2020 Jul;42(7):1355-1360. doi: 10.1002/hed.26366.
4
Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.LATS2 基因启动子甲基化在北印度人群口腔鳞状细胞癌(OSCC)中的作用。
Asian Pac J Cancer Prev. 2020 May 1;21(5):1283-1287. doi: 10.31557/APJCP.2020.21.5.1283.
5
Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis.PD-L1 过表达在口腔鳞状细胞癌中的预后及临床病理意义:系统评价和综合荟萃分析。
Oral Oncol. 2020 Jul;106:104722. doi: 10.1016/j.oraloncology.2020.104722. Epub 2020 Apr 21.
6
Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.同步放化疗治疗局部晚期非小细胞肺癌患者中肿瘤细胞 PD-L1 表达与 CD8+TIL 密度的预后价值。
Radiat Oncol. 2020 Jan 2;15(1):5. doi: 10.1186/s13014-019-1453-3.
7
The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials.PD-L1表达与抗PD-1/PD-L1免疫疗法疗效及非小细胞肺癌患者生存的相关性:一项随机对照试验的荟萃分析。
Transl Lung Cancer Res. 2019 Aug;8(4):413-428. doi: 10.21037/tlcr.2019.08.09.
8
PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancer.PD-1和PD-L1相关基因表达谱及其与乳腺癌临床结局的关联
Cancer Cell Int. 2019 Sep 9;19:233. doi: 10.1186/s12935-019-0955-2. eCollection 2019.
9
Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect: A Systematic Review.除远隔效应外,提高癌症免疫检查点抑制剂疗效的策略:一项系统综述
Cancers (Basel). 2019 Apr 15;11(4):539. doi: 10.3390/cancers11040539.
10
Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading.乳腺癌的免疫检查点阻断治疗策略:现状与未来。
Curr Treat Options Oncol. 2019 Mar 28;20(4):35. doi: 10.1007/s11864-019-0634-5.